(February 16, 2024, 2:03 PM EST) -- SAN FRANCISCO — A federal judge in California issued an order granting preliminary approval of a settlement in a class complaint brought by investors who said a biopharmaceutical company misled investors through a series of material misrepresentations regarding a clinical trial for a new anemia treatment drug....